These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 34547499)

  • 1. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
    Michalski JE; Kurche JS; Schwartz DA
    Transl Res; 2022 Mar; 241():13-24. PubMed ID: 34547499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healing after COVID-19: are survivors at risk for pulmonary fibrosis?
    McDonald LT
    Am J Physiol Lung Cell Mol Physiol; 2021 Feb; 320(2):L257-L265. PubMed ID: 33355522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alveolar fibroproliferative response in moderate to severe COVID-19-related acute respiratory distress syndrome and 1-yr follow-up.
    Zhang S; Boers LS; de Brabander J; van den Heuvel LB; Blok SG; Kullberg RFJ; Smids-Dierdorp BS; Dekker T; Aberson HL; Meijboom LJ; Vlaar APJ; Heunks L; Nossent EJ; van der Poll T; Bos LDJ; Duitman J;
    Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L7-L18. PubMed ID: 37933449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung recovery with prolonged ECMO following fibrotic COVID-19 acute respiratory distress syndrome.
    Kazi AW; Summer R; Sundaram B; George G
    Am J Med Sci; 2023 Mar; 365(3):307-312. PubMed ID: 36535539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three Cases of COVID-19 Pneumonia in Female Patients in Italy Who Had Pulmonary Fibrosis on Follow-Up Lung Computed Tomography Imaging.
    Picchi G; Mari A; Ricciardi A; Carucci AC; Sinatti G; Cosimini B; Di Norcia M; Iapadre N; Balsano C; Grimaldi A
    Am J Case Rep; 2020 Nov; 21():e926921. PubMed ID: 33219200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19.
    Hasegawa T; Nakagawa A; Suzuki K; Yamashita K; Yamashita S; Iwanaga N; Tamada E; Noda K; Tomii K
    Cytokine; 2021 Dec; 148():155618. PubMed ID: 34127355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary fibrosis in COVID-19: mechanisms, consequences and targets.
    O'Reilly S
    QJM; 2023 Oct; 116(9):750-754. PubMed ID: 37191984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment.
    Rumende CM
    Acta Med Indones; 2021 Apr; 53(2):141-142. PubMed ID: 34251340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the pathophysiology of typical acute respiratory distress syndrome and severe COVID-19.
    Ball L; Silva PL; Giacobbe DR; Bassetti M; Zubieta-Calleja GR; Rocco PRM; Pelosi P
    Expert Rev Respir Med; 2022 Apr; 16(4):437-446. PubMed ID: 35341424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive Pulmonary Fibrosis After Non-Critical COVID-19: A Case Report.
    Doane JJ; Hirsch KS; Baldwin JO; Wurfel MM; Pipavath SN; West TE
    Am J Case Rep; 2021 Dec; 22():e933458. PubMed ID: 34848676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the ACE2/Ang-(1-7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19.
    Morganstein T; Haidar Z; Trivlidis J; Azuelos I; Huang MJ; Eidelman DH; Baglole CJ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe COVID-19 with acute respiratory distress syndrome (ARDS) in a sickle cell disease adult patient: case report.
    Teulier M; Elabbadi A; Gerotziafas G; Lionnet F; Voiriot G; Fartoukh M
    BMC Pulm Med; 2021 Jan; 21(1):46. PubMed ID: 33514354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target.
    Ntatsoulis K; Karampitsakos T; Tsitoura E; Stylianaki EA; Matralis AN; Tzouvelekis A; Antoniou K; Aidinis V
    Front Immunol; 2021; 12():687397. PubMed ID: 34671341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies.
    Ojo AS; Balogun SA; Williams OT; Ojo OS
    Pulm Med; 2020; 2020():6175964. PubMed ID: 32850151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-COVID syndrome: pulmonary complications.
    Esendağli D; Yilmaz A; Akçay Ş; Özlü T
    Turk J Med Sci; 2021 Dec; 51(SI-1):3359-3371. PubMed ID: 34284532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
    Zheng Z; Peng F; Zhou Y
    Chin Med J Pulm Crit Care Med; 2023 Jun; 1(2):77-83. PubMed ID: 37388822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium.
    Moal B; Orieux A; Ferté T; Neuraz A; Brat GA; Avillach P; Bonzel CL; Cai T; Cho K; Cossin S; Griffier R; Hanauer DA; Haverkamp C; Ho YL; Hong C; Hutch MR; Klann JG; Le TT; Loh NHW; Luo Y; Makoudjou A; Morris M; Mowery DL; Olson KL; Patel LP; Samayamuthu MJ; Sanz Vidorreta FJ; Schriver ER; Schubert P; Verdy G; Visweswaran S; Wang X; Weber GM; Xia Z; Yuan W; Zhang HG; Zöller D; Kohane IS; ; Boyer A; Jouhet V
    PLoS One; 2023; 18(1):e0266985. PubMed ID: 36598895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel coronavirus disease (COVID-19) complicated by pulmonary embolism and acute respiratory distress syndrome.
    Li T; Cheng GS; Pipavath SNJ; Kicska GA; Liu L; Kinahan PE; Wu W
    J Med Virol; 2020 Oct; 92(10):2205-2208. PubMed ID: 32470156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax.
    Guven BB; Erturk T; Kompe Ö; Ersoy A
    Epidemiol Infect; 2021 Jun; 149():e137. PubMed ID: 34099076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.